Roxee Medication Guide

Meloxicam

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Suspension) Multiple FDA labelers Official label facts Owner quick guide first

Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts

Reference refreshed

Aug 6, 2026, 7:47 p.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications

FDA application data refreshed

Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports

Safety data refreshed

Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:46 PM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Jul 1, 2026, 11:44 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Illustration placeholder

Meloxicam

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Liquid (Suspension) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Meloxicam

For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. For the control of pain and inflammation associated with osteoarthritis in dogs. Species commonly shown: Both, Dog, Cat.

Generic name

Meloxicam

Brand names

Metacam® Oral Suspension, Metacam® 5 mg/mL Solution for Injection, OroCAM® Transmucosal Oral Spray, Meloxicam Injection

Manufacturer

Multiple FDA labelers

Species

Both, Dog, Cat

Dosage forms

Liquid (Suspension), Liquid (Solution), Transmucosal Oral Spray, Sterile Solution

Prescription

Prescription required

Completeness

100%

Validation

Complete

Brand names

Metacam® Oral Suspension Metacam® 5 mg/mL Solution for Injection OroCAM® Transmucosal Oral Spray Meloxicam Injection Loxicom® Meloxicam Solution for Injection Meloxidyl® Meloxicam Meloxisol™ Meloxicam Oral Suspension X Metacam Meloxivet MELOXIDYL Loxicom OstiLox Alloxate

Dosage forms

Liquid (Suspension) Liquid (Solution) Transmucosal Oral Spray Sterile Solution Solution For Injection Oral Suspension Injectable Solution

Indications / Uses

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in 'Neurological'), Anorexia, Death by euthanasia, Death.

FAQ

Both, Dog, Cat

Yes. Roxee shows this as prescription-only.

Liquid (Suspension), Liquid (Solution), Transmucosal Oral Spray, Sterile Solution

Related Medications

Related Conditions

Osteoarthritis (Degenerative Joint Disease) Osteoarthritis (Degenerative Joint Disease) Pain (acute, chronic)

Source Transparency

Verified source: https://www.roxee.ai/meds/
Verified source: https://animaldrugsatfda.fda.gov
Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
Verified source: https://api.fda.gov/animalandveterinary/event.json
Verified source: https://www.roxee.ai/conditions/
Verified source: https://www.accessdata.fda.gov/spl/data/c0edc57c-2feb-497d-8187-51ed60205a8a/c0edc57c-2feb-497d-8187-51ed60205a8a.xml
Last refreshed: Aug 6, 2026, 7:47 p.m.
Last verified: Feb 12, 2026, 10:44 p.m.
Validation status: Complete

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Meloxicam Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

For oral use in dogs only
Do not use in cats
Acute renal failure and death have been associated with the use of meloxicam in cats
Repeated use of meloxicam in cats has been associated with acute renal failure and death
Do not administer additional injectable or oral meloxicam to cats
wobbly/unsteady walking (1 reports)
Loss of appetite (1 reports)
Blood in vomit (1 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Meloxicam; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-013066

Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 24 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-013066

Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-013066

Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Unsteady walking (ataxia) (1 reports), Loss of appetite (1 reports), Blood in vomit (1 reports), Blood in urine (1 reports), Behavioral disorder (unspecified) (1 reports)

Body systems represented Signal grouping

Digestive (3), Skin & allergy (3), Neurologic (1), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (16 reports), Cat (16 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (2), Retriever - Golden (2), Spaniel - King Charles Cavalier (2), Domestic Mediumhair (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Meloxicam fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

For oral use in dogs only, Do not use in cats, Acute renal failure and death have been associated with the use of meloxicam in cats, Repeated use of meloxicam in cats has been associated with acute renal failure and death, Do not administer additional injectable or oral meloxicam to cats

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Meloxicam brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.

Vet source depth

openFDA case USA-USFDACVM-2026-US-013066 · adverse_reaction · adverse reactions
Contraindication source · fda_animal_drugs · warnings contraindications
FDA application profile · official_label · quick facts
FDA application profile · official_label · quick facts
Medication usage source · fda_animal_drugs · quick facts
FOI · document · documents
Labeling · document · documents
SPL · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: February 12, 2026, 10:44 PM UTC

Sources:

FDA application profile · official_label
FDA application profile · official_label
Medication usage source · fda_animal_drugs
Meloxisol™ · official_label
openFDA case USA-USFDACVM-2026-US-013066 · adverse_reaction

Safety & side effects

Side effects to monitor:

For oral use in dogs only
Do not use in cats
Acute renal failure and death have been associated with the use of meloxicam in cats
Repeated use of meloxicam in cats has been associated with acute renal failure and death
Do not administer additional injectable or oral meloxicam to cats

Most reported reactions:

Unsteady walking (ataxia) (1 reports)
Loss of appetite (1 reports)
Blood in vomit (1 reports)

Explore reported case details

Emergency warning signs:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species

Cat, Dog

Indication / use

Meloxicam Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Form / route / dose

Form: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution, Transmucosal Oral Spray
Route: Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.

Warnings

High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not…

Adverse-event caveat

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Source docs

A-200856-A-0000-OT-AA_PI.pdf Official label / PI
A-200786-E-0003-OT-AA_PI.pdf Official label / PI
A-200727-G-0031-FL-AA_PI.pdf Official label / PI

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Multiple FDA labelers

Form: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution

Identifiers:

ANADA: 200485 ANADA: 200491 ANADA: 200497 ANADA: 200540 ANADA: 200550 ANADA: 200727 ANADA: 200786 ANADA: 200794 ANADA: 200816 ANADA: 200817 ANADA: 200856 NADA: 141213 NADA: 141219 NADA: 141346 NDC Package: 0010-6013-01 NDC Package: 0010-6014-01 NDC Package: 0010-6014-02 NDC Package: 0010-6015-01 NDC Package: 0010-6015-02 NDC Package: 0010-6015-03

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200856 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200786 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source

Warnings / Contraindications

High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Source metadata:

https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Stored reports

Matching reports

Active filters

Selected filters

Reaction: Diarrhoea Clear

Species

Breed

Size / weight

Age

Sex

Seriousness

Outcome

Reaction

Body system

Region

Received after

Received before

Reset

Drill into common report signals

Vomiting (8) Diarrhoea (5) Anaemia NOS (4) Dilated pupils (4) Other (40) Digestive (13) Skin & allergy (13) Effectiveness (4)

Showing up to 50 matching reports.

USA-USFDACVM-2026-US-012695

Received 2026-03-13 · MSK · MSK

Serious

Species: Dog
Breed: Dalmatian
Size / weight: 50-99 lb (36.741 Kilogram)
Age: 8+ years (1 Year)
Sex: Male Neutered
Region: USA
Reactions: AgitationDroolingFebrilePantingAnaphylaxisUnwellDecreased appetiteUrinary incontinenceVomitingDiarrhoeaLeukocytosis NOSNeutrophiliaLymphocytosisMonocytosisElevated globulinsElevated serum alkaline phosphatase (ALP)Anaemia NOSElevated alanine aminotransferase (ALT)Elevated C-reactive proteinAggressionUrolithiasisAutoimmune disorder NOSThrombocytopenia
Body systems: OtherDigestiveBehavior
Outcomes: Ongoing

USA-USFDACVM-2025-US-075145

Received 2025-12-23 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (4.717 Kilogram)
Age: 8+ years (13 Year)
Sex: Male Neutered
Region: USA
Reactions: Diarrhoea
Body systems: Digestive
Outcomes: Ongoing

USA-USFDACVM-2025-US-074369

Received 2025-12-17 · MSK · MSK

Non-serious

Species: Dog
Breed: Chihuahua
Size / weight: Under 10 lb (3.175 Kilogram)
Age: 4-7 years (4 Year)
Sex: Male Neutered
Region: USA
Reactions: DiarrhoeaAnorexiaLack of efficacy - NOS
Body systems: DigestiveEffectiveness
Outcomes: Recovered/Normal

USA-USFDACVM-2025-US-074255

Received 2025-12-15 · MSK · MSK

Non-serious

Species: Dog
Breed: Terrier - Jack Russell
Size / weight: 10-24 lb (6.214 Kilogram)
Age: 8+ years (13 Year)
Sex: Female Unknown
Region: USA
Reactions: Inappropriate elimination NOSProprioception deficitWeight lossVomitingDiarrhoeaProteinuriaElevated globulinsNeutrophiliaAbnormal radiograph finding
Body systems: OtherDigestive
Outcomes: Ongoing

USA-USFDACVM-2025-US-071574

Received 2025-12-05 · MSK · MSK

Serious

Species: Dog
Breed: Spitz - German Pomeranian
Size / weight: Under 10 lb (1.633 Kilogram)
Age: 4-7 years (4 Year)
Sex: Female Neutered
Region: USA
Reactions: Decreased appetiteVomiting bileDiarrhoeaElectrolyte disorderHypoalbuminaemiaDecreased cholesterol (total)Low creatinineWeight loss
Body systems: DigestiveOther
Outcomes: Ongoing

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Digestive (3) · Loss of appetite, Blood in vomit, Appetite loss Skin & allergy (3) · Hair loss at application site, Biting - pruritus, Application site hair loss Neurologic (1) · Unsteady walking (ataxia) Behavior (2) · Behavioral disorder (unspecified), Aggression Other (23) · Blood in urine, Balance problem, Azotaemia

Most Reported Reactions

Body system	Cases	Species	Serious cases
Neurologic	1	Dog	1
Digestive	1	Cat	1
Digestive	1	Cat	1
Other	1	Cat	1
Behavior	1	Cat	1
Other	1	Cat	1
Other	1	Dog	1
Other	1	Dog	1

Species coverage: Dog (16) Cat (16)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Neurologic	Dog	Serious	-	1
Digestive	Cat	Serious	-	1
Skin & allergy	Cat	Non-serious	-	1
Digestive	Cat	Serious	-	1
Other	Cat	Serious	-	1
Skin & allergy	Dog	Non-serious	-	1
Behavior	Cat	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Skin & allergy	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Digestive	Cat	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Behavior	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2026-US-013066

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

A-200856-A-0000-OT-AA_PI.pdf Official label / PI · Labeling A-200786-E-0003-OT-AA_PI.pdf Official label / PI · Labeling A-200727-G-0031-FL-AA_PI.pdf Official label / PI · Labeling

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

No owner handouts linked yet.

Official label / PI

SPL

Open original

FDA Structured Product Label

Meloxicam Oral Suspension

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: ZyVet Animal Health, Inc.
ANADA: 200-856
Status: RX
Form: Oral Suspension
Route: Oral

Composition / specifications

Each milliliter of suspension contains 1.5 mg meloxicam

Dogs

Indication

Meloxicam Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Loxicom®

SPL · SPL

Open original

FDA Structured Product Label

Loxicom®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Norbrook Laboratories, Ltd.
ANADA: 200-786
Status: RX
Form: Oral Suspension
Route: Oral

Composition / specifications

0.5 mg/mL

Dogs

Indication

Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on thefirst day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Meloxisol™

SPL · SPL

Open original

FDA Structured Product Label

Meloxisol™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
ANADA: 200-794
Status: RX
Form: Oral Suspension
Route: Oral

Composition / specifications

Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Meloxicam Oral Suspension

SPL · SPL

Open original

FDA Structured Product Label

Meloxicam Oral Suspension

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Felix Pharmaceuticals Pvt. Ltd.
ANADA: 200-817
Status: RX
Form: Oral Suspension
Route: Oral

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Meloxisol™

SPL · SPL

Open original

FDA Structured Product Label

Meloxisol™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
ANADA: 200-816
Status: RX
Form: Oral Suspension
Route: Oral

Composition / specifications

1.5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Meloxicam

SPL · SPL

Open original

FDA Structured Product Label

Meloxicam

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Felix Pharmaceuticals Pvt. Ltd.
ANADA: 200-727
Status: RX
Form: Injectable Solution
Route: Intravenous, Subcutaneous
Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Meloxicam injection should be administered initially as a single dose, at0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose of Meloxicam injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated. To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended.

Metacam® 5 mg/mL Solution for Injection

SPL · SPL

Open original

FDA Structured Product Label

Metacam® 5 mg/mL Solution for Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Boehringer Ingelheim Animal Health USA, Inc.
NADA: 141-219
Status: RX
Form: Liquid (Solution)
Route: Subcutaneous, Intravenous
Species: Dog • Cat

Composition / specifications

Each milliliter of solution contains 5.0 milligrams (mg) meloxicam.

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery.

Dosage

Administer 0.14 mg/lb (0.3 milligram per kilogram) body weight as a single, one-time subcutaneous injection.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Administer 0.09 mg per pound (0.2 milligram per kilogram) body weight by intravenous or subcutaneous injection on the first day of treatment. For treatment after day 1, administer meloxicam suspension orally at 0.045 mg/lb (0.1 milligram per kilogram) body weight once daily.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Metacam® Oral Suspension

SPL · SPL

Open original

FDA Structured Product Label

Metacam® Oral Suspension

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Boehringer Ingelheim Animal Health USA, Inc.
NADA: 141-213
Status: RX
Form: Liquid (Suspension)
Route: Oral
Species: Dog

Composition / specifications

Each milliliter of suspension contains 0.5 or 1.5 milligrams (mg) meloxicam.

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.

Limitations

Meloxicam Injection

SPL · SPL

Open original

FDA Structured Product Label

Meloxicam Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Accord Healthcare, Inc.
ANADA: 200-485
Status: RX
Form: Sterile Solution
Route: Subcutaneous, Intravenous
Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated.

Limitations

Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.

Loxicom®

SPL · SPL

Open original

FDA Structured Product Label

Loxicom®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Norbrook Laboratories, Ltd.
ANADA: 200-491
Status: RX
Form: Solution For Injection
Route: Intravenous, Subcutaneous
Species: Dog • Cat

Composition / specifications

5 mg/mL meloxicam solution

Dogs

Indication

Indicated in dogs for the control of pain and inflammation associated with osteoarthritis.

Dosage

Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously |IV| or subcutaneously (SQ), fallowed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight either mixed with food or placed directly in the mouth.

Limitations

Do not administer a second dose of meloxicam. Do not follow the single, one-time dose of meloxicam with any other NSAID. Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.

Cats

Indication

For the control ot postoperative pain and inflammation associated with orthopedic surgery, ovariohystarectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight.

Limitations

Meloxicam Solution for Injection

SPL · SPL

Open original

FDA Structured Product Label

Meloxicam Solution for Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Dechra Veterinary Products LLC
ANADA: 200-540
Status: RX
Form: Sterile Solution
Route: Intravenous, Subcutaneous
Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis

Dosage

Meloxicam Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery

Dosage

Administer a single, one-time subcutaneous dose of Meloxicam Solution for Injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

Loxicom®

SPL · SPL

Open original

FDA Structured Product Label

Loxicom®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Norbrook Laboratories, Ltd.
ANADA: 200-497
Status: RX
Form: Oral Suspension
Route: Oral
Species: Dog

Composition / specifications

1.5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

On the first day of treatment, administer 0.09 mg/lb (0.2 mg/kg). For all treatments after day 1, administer once daily at a dose of 0.045 mg/lb (0.1 mg/ kg).

Limitations

For oral use in dogs only.

Meloxidyl®

SPL · SPL

Open original

FDA Structured Product Label

Meloxidyl®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Ceva Sante Animale
ANADA: 200-550
Status: RX
Form: Oral Suspension
Route: Oral
Species: Dog

Composition / specifications

Each milliliter of suspension contains 1.5 milligrams (mg) meloxicam.

Label highlights

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

OroCAM® Transmucosal Oral Spray

SPL · SPL

Open original

FDA Structured Product Label

OroCAM® Transmucosal Oral Spray

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Zoetis Inc.
NADA: 141-346
Status: RX
Form: Transmucosal Oral Spray
Route: Oral
Species: Dog

Composition / specifications

Each milliliter of solution contains 5 milligrams (mg) meloxicam.

Dogs

FOI · FOI

Open original

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/18572 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/2560 · document · Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18852/Meloxicam%20Oral%20Suspension · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/18346 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/2479 · document · Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18646/Loxicom%C2%AE · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17325 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17646/Meloxisol%E2%84%A2 · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17255 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17566/Meloxicam%20Oral%20Suspension · document · SPL

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:46 PM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Jul 1, 2026, 11:44 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Official (FDA)

Identity: Generic ingredient • FDA branded products available

Official FDA brands: Alloxate Loxicom MELOXIDYL Meloxicam Meloxivet Metacam OstiLox Ostilox X

Manufacturer mapping: Multiple FDA labelers

Case-reported brands (openFDA): MSK

Catalog species: Both • FDA-labeled species: Cat, Dog

Rx/OTC: RX

Form/route: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution, Transmucosal Oral Spray • Intravenous, Oral, Subcutaneous

Applications: ANADA 200-856 • ANADA 200-786 • ANADA 200-794 • ANADA 200-817 • ANADA 200-816 • ANADA 200-727 • NADA 141-219 • NADA 141-213 • ANADA 200-485 • ANADA 200-491 • ANADA 200-540 • ANADA 200-497 • ANADA 200-550 • NADA 141-346

NDC: Packages 0010-6013-01 0010-6014-01 0010-6014-02 0010-6015-01 0010-6015-02 0010-6015-03 • Products 0010 11695 13744 13985 17033 46066

Documents: 33 (FOI: 16) • SPL: 14 • Label highlights • Official documents

Safety (openFDA)

Top reactions: Dog 113 • Cat 82 • View

Case summaries: 43 (showing 8) • View

openFDA reports are unverified and do not prove causation.

Explore

Related conditions: Osteoarthritis (Degenerative Joint Disease) Osteoarthritis (Degenerative Joint Disease) Pain (acute, chronic)

Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)

Diagnosis Codes

ICD10_CM: M19.90

Unspecified osteoarthritis, unspecified site

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)

Top reaction signals

Unsteady walking (ataxia) (1) Loss of appetite (1) Blood in vomit (1) Blood in urine (1) Behavioral disorder (unspecified) (1) Balance problem (1) Azotaemia (1) Autoimmune disorder NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers

Package NDC	Product NDC	Status
0010-6013-01	0010	-
0010-6014-01	0010	-
0010-6014-02	0010	-
0010-6015-01	0010	-
0010-6015-02	0010	-
0010-6015-03	0010	-
0010-6015-04	0010	-
11695-6936-1	11695	-
11695-6936-2	11695	-
11695-6966-1	11695	-
11695-6966-2	11695	-
11695-6966-3	11695	-
11695-6966-4	11695	-
11695-7008-1	11695	-
11695-7008-2	11695	-
11695-7050-1	11695	-
11695-7067-1	11695	-
11695-7067-2	11695	-
13744-505-01	13744	-
13744-505-10	13744	-

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

OstiLox SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Loxicom SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Metacam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Loxicom SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Ostilox SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
MELOXIDYL SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Loxicom SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
OstiLox SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
MELOXIDYL SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
MELOXIDYL SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Metacam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
MELOXIDYL SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Metacam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Alloxate SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
OstiLox SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxivet SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
X SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
OstiLox SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Meloxicam SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
A-200856-A-0000-OT-AA_PI.pdf • Official label • Official • July 1, 2026
FDA official labeling for application 200856
FOI Summary oA 200-856 Approved June 22, 2026.pdf • FOI summary • Official • July 1, 2026
FDA FOI summary for application 200856
A-200786-E-0003-OT-AA_PI.pdf • Official label • Official • June 30, 2026
FDA official labeling for application 200786
FOI Summary oA 200-786 Approved April 20, 2026.pdf • FOI summary • Official • June 30, 2026
FDA FOI summary for application 200786
FOI Summary oA 200-794 Approved August 14, 2025.pdf • FOI summary • Official • Aug. 28, 2025
FDA FOI summary for application 200794
FOI Summary oA 200-817 Approved July 21, 2025.pdf • FOI summary • Official • July 31, 2025
FDA FOI summary for application 200817
FOI Summary oA 200-816 Approved July 11, 2025.pdf • FOI summary • Official • July 31, 2025
FDA FOI summary for application 200816
A-200727-G-0031-FL-AA_PI.pdf • Official label • Official • Nov. 7, 2024
FDA official labeling for application 200727
FOI Summary oA 200-727 Approved July 29, 2022.pdf • FOI summary • Official • Nov. 7, 2024
FDA FOI summary for application 200727
N-141219-C-0098-NL-AA_PI.pdf • Official label • Official • March 1, 2024
FDA official labeling for application 141219
ucm118026.pdf • FOI summary • Official • March 1, 2024
FDA FOI summary for application 141219
ucm118027.pdf • FOI summary • Official • March 1, 2024
FDA FOI summary for application 141219

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 180 Clinical 1 Manufacturer 0 Marketing 0

Current Field Facts

side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in 'Neurological'), Anorexia, Death by euthanasia, … (Clinical, 2026-04-11)
contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-04-12)
contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-04-11)
contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-02-12)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-06)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-05)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-04)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-03)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-02)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-08-01)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-31)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-30)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-29)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-28)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-27)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-26)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-25)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-25)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-22)
indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-07-22)

Recent Revisions

side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product	Sponsor	Application	Status	Published
Meloxicam Oral Suspension RX Meloxicam Oral Suspension • Oral Label highlights Official documents	ZyVet Animal Health, Inc.	ANADA 200-856	Approved	Jul 1, 2026
Loxicom® RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Norbrook Laboratories, Ltd.	ANADA 200-786	Approved	Jun 30, 2026
Meloxisol™ RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Cronus Pharma Specialities India Private Ltd.	ANADA 200-794	Approved	Aug 28, 2025
Meloxicam Oral Suspension RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Felix Pharmaceuticals Pvt. Ltd.	ANADA 200-817	Approved	Jul 31, 2025
Meloxisol™ RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Cronus Pharma Specialities India Private Ltd.	ANADA 200-816	Approved	Jul 31, 2025
Meloxicam RX Meloxicam Injectable Solution • Intravenous, Subcutaneous Label highlights Official documents	Felix Pharmaceuticals Pvt. Ltd.	ANADA 200-727	Approved	Nov 7, 2024
Metacam® 5 mg/mL Solution for Injection RX Meloxicam Liquid (Solution) • Subcutaneous, Intravenous Label highlights Official documents	Boehringer Ingelheim Animal Health USA, Inc.	NADA 141-219	Approved	Mar 1, 2024
Metacam® Oral Suspension RX Meloxicam Liquid (Suspension) • Oral Label highlights Official documents	Boehringer Ingelheim Animal Health USA, Inc.	NADA 141-213	Approved	Dec 21, 2023
Meloxicam Injection RX Meloxicam Sterile Solution • Subcutaneous, Intravenous Label highlights Official documents	Accord Healthcare, Inc.	ANADA 200-485	Approved	Jan 31, 2023
Loxicom® RX Meloxicam Solution For Injection • Intravenous, Subcutaneous Label highlights Official documents	Norbrook Laboratories, Ltd.	ANADA 200-491	Approved	Aug 2, 2021
Meloxicam Solution for Injection RX Meloxicam Sterile Solution • Intravenous, Subcutaneous Label highlights Official documents	Dechra Veterinary Products LLC	ANADA 200-540	Approved	Aug 18, 2020
Loxicom® RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Norbrook Laboratories, Ltd.	ANADA 200-497	Approved	Feb 27, 2019
Meloxidyl® RX Meloxicam Oral Suspension • Oral Label highlights Official documents	Ceva Sante Animale	ANADA 200-550	Approved	Dec 21, 2018
OroCAM® Transmucosal Oral Spray RX Meloxicam Transmucosal Oral Spray • Oral Label highlights Official documents	Zoetis Inc.	NADA 141-346	Approved	Nov 13, 2017

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications

Each milliliter of suspension contains 1.5 mg meloxicam

Dogs

Indication

Meloxicam Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications

0.5 mg/mL

Dogs

Indication

Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on thefirst day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications

Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications

1.5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

Each milliliter of solution contains 5.0 milligrams (mg) meloxicam.

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery.

Dosage

Administer 0.14 mg/lb (0.3 milligram per kilogram) body weight as a single, one-time subcutaneous injection.

Limitations

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog

Composition / specifications

Each milliliter of suspension contains 0.5 or 1.5 milligrams (mg) meloxicam.

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated.

Limitations

Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

5 mg/mL meloxicam solution

Dogs

Indication

Indicated in dogs for the control of pain and inflammation associated with osteoarthritis.

Dosage

Limitations

Cats

Indication

For the control ot postoperative pain and inflammation associated with orthopedic surgery, ovariohystarectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

Cats

Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog

Composition / specifications

1.5 mg/mL

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

On the first day of treatment, administer 0.09 mg/lb (0.2 mg/kg). For all treatments after day 1, administer once daily at a dose of 0.045 mg/lb (0.1 mg/ kg).

Limitations

For oral use in dogs only.

FDA page: Open in Animal Drugs @ FDA

Species: Dog

Composition / specifications

Each milliliter of suspension contains 1.5 milligrams (mg) meloxicam.

Label highlights

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog

Composition / specifications

Each milliliter of solution contains 5 milligrams (mg) meloxicam.

Dogs

Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer 0.1 mg per kilogram of body weight once daily using the metered dose pump.

Limitations

FDA page: Open in Animal Drugs @ FDA

Usage

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive

Loss of appetite (1) • Cat Blood in vomit (1) • Cat Appetite loss (1) • Cat

Showing top 5 for Digestive.

Skin & allergy

Hair loss at application site (1) • Cat Biting - pruritus (1) • Dog Application site hair loss (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic

Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior

Behavioral disorder (1) • Cat Aggression (1) • Dog

Showing top 5 for Behavior.

Other

Blood in urine (1) • Cat Balance problem (1) • Cat Azotaemia (1) • Dog Autoimmune disorder NOS (1) • Dog Aspiration pneumonia (1) • Dog

Show more (18)

Application site skin scaling (1) • Cat Application site reddening (1) • Cat Application site lesion (1) • Cat Application site discharge NOS (1) • Cat Anisocoria (1) • Cat Anaphylaxis (1) • Dog Anaemia NOS (1) • Dog Agitation (1) • Dog Adipsia (1) • Cat Abnormal ultrasound finding (1) • Dog Abnormal red blood cell (1) • Dog Abnormal radiograph finding (1) • Dog Abnormal pupil light reflex (1) • Cat Abnormal posture NOS (1) • Dog Abnormal movement NOS (1) • Cat Abnormal cytology (1) • Dog Abdominal pain (1) • Dog Abdominal effusion (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Female, 14 year, 6.895 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Licking, Localised hair loss, Skin scab, Elevated creatine-kinase, Medication error NOS • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-014453
Serious AE: No
Treated For AE: No
Sex: Female
Age: 14.00 Year
Weight: 6.895 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Unassigned

Reactions Reported:

Licking Localised hair loss Skin scab Elevated creatine-kinase Medication error NOS

Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 6 month, 2.72 kilogram • Drug: MSK, Unknown • Reactions: Tongue ulceration • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2026-US-013871
Serious AE: No
Treated For AE: Yes
Sex: Female
Age: 6.00 Month
Weight: 2.720 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Tongue ulceration

Outcomes: Recovered/Normal

Cat, Domestic Mediumhair, Female, 6 month, 2.95 kilogram • Drug: MSK, Unknown • Reactions: Tongue ulceration • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2026-US-013856
Serious AE: No
Treated For AE: Yes
Sex: Female
Age: 6.00 Month
Weight: 2.950 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Tongue ulceration

Outcomes: Recovered/Normal

Dog, Retriever - Golden, Female, 13 year, 23.315 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Urinary tract infection, Lymphadenopathy, Elevated globulins, Abnormal cytology • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-013427
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 13.00 Year
Weight: 23.315 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Urinary tract infection Lymphadenopathy Elevated globulins Abnormal cytology

Outcomes: Ongoing

Dog, Retriever - Golden, Female, 2 year, 27.216 kilogram • Drug: MSK, Suspension, Oral, Dose: 2.70 Milligram per dose, Frequency: 24 per hour • Reactions: Vomiting, Loss of appetite, Azotaemia, Electrolyte disorder, Hypercortisolaemia… • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-013309
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 2.00 Year
Weight: 27.216 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Suspension
Dose: 2.70 Milligram per dose
Frequency: 24 per hour

Reactions Reported:

Vomiting Loss of appetite Azotaemia Electrolyte disorder Hypercortisolaemia Hyperphosphataemia Abdominal effusion White blood cell disorder NOS Thrombocytopenia

Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 13 year • Drug: MSK, Suspension, Oral, Dose: 1 Unknown per animal • Reactions: Haematochezia, Anaemia NOS • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2026-US-013629
Serious AE: No
Treated For AE: Yes
Sex: Male
Age: 13.00 Year

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Suspension
Dose: 1 Unknown per animal

Reactions Reported:

Haematochezia Anaemia NOS

Outcomes: Outcome Unknown

Dog, Spaniel - King Charles Cavalier, Male, 9 year • Drug: MSK, Suspension, Oral, Dose: 1 Unknown per animal • Reactions: Haematochezia, Anaemia NOS • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2026-US-013628
Serious AE: No
Treated For AE: Yes
Sex: Male
Age: 9.00 Year

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Suspension
Dose: 1 Unknown per animal

Reactions Reported:

Haematochezia Anaemia NOS

Outcomes: Outcome Unknown

Dog, Spaniel - King Charles Cavalier, Female, 2 year • Drug: MSK, Suspension, Oral, Dose: 1 Unknown per animal • Reactions: Haematochezia, Anaemia NOS • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2026-US-013627
Serious AE: No
Treated For AE: Yes
Sex: Female
Age: 2.00 Year

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Suspension
Dose: 1 Unknown per animal

Reactions Reported:

Haematochezia Anaemia NOS

Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

No community reviews yet. Be the first to share your experience.

This medication has not been reviewed by a veterinarian yet.

Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.

Meloxicam

Data freshness

Meloxicam

Medication Snapshot

Meloxicam

Indications / Uses

Warnings / Contraindications

Side Effects

FAQ

What species is this commonly shown for?

Does this usually require a prescription?

What dosage forms are listed?

Related Medications

Related Conditions

Source Transparency

Add to My Pet's Medications

Pet Owner Quick Guide

Next actions

Medication Research Insights

What to know

Evidence tension

Reaction signal map

Species and breed lens

What your vet may verify

What to watch next

Evidence

Vet Fast Scan

Quick Facts

Warnings / Contraindications

Adverse Reactions

Reported case explorer

USA-USFDACVM-2026-US-012695

USA-USFDACVM-2025-US-075145

USA-USFDACVM-2025-US-074369

USA-USFDACVM-2025-US-074255

USA-USFDACVM-2025-US-071574

Grouped by Body System

Most Reported Reactions

Source Documents

Owner handouts

Official label / PI

SPL

FOI

A-200856-A-0000-OT-AA_PI.pdf

A-200786-E-0003-OT-AA_PI.pdf

A-200727-G-0031-FL-AA_PI.pdf

N-141219-C-0098-NL-AA_PI.pdf

UCM050394.pdf

UCM422143.pdf

N-141213-G-0122-FL-AA_CIS.pdf

N-141213-G-0122-FL-AA_CIS.pdf

A-200485-C-0047-NL-AA_PI.pdf

A-200491-C-0034-NL-AA_PI.pdf

A-200540-C-0029-NL-AA_PI.pdf

A200497_Client_Info_Sheet.pdf

A200497_Package_Insert.pdf

ANADA 200550 Package Insert and Client Info Sheet for Dogs.pdf

ANADA 200550 Package Insert and Client Info Sheet for Dogs.pdf

UCM342580.pdf

UCM422174.pdf

Meloxicam Oral Suspension

Meloxicam Oral Suspension

Dogs

Loxicom®

Loxicom®

Dogs

Meloxisol™

Meloxisol™

Dogs

Meloxicam Oral Suspension

Meloxicam Oral Suspension

Dogs

Meloxisol™

Meloxisol™

Dogs

Meloxicam

Meloxicam

Dogs

Cats

Metacam® 5 mg/mL Solution for Injection